Aquilo Capital Management, LLC has filed its 13F form on May 15, 2024 for Q1 2024 where it was disclosed a total value porftolio of $128 Million distributed in 10 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Arrowhead Pharmaceuticals, Inc. with a value of $26M, Regenxbio Inc. with a value of $19.1M, Blueprint Medicines Corp with a value of $17.3M, Arvinas, Inc. with a value of $16.8M, and Kymera Therapeutics, Inc. with a value of $15.6M.

Examining the 13F form we can see an decrease of $32.3M in the current position value, from $160M to 128M.

Aquilo Capital Management, LLC is based out at San Francisco, CA

Below you can find more details about Aquilo Capital Management, LLC portfolio as well as his latest detailed transactions.

Portfolio value $128 Million
Healthcare: $128 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 10
  • Current Value $128 Million
  • Prior Value $160 Million
  • Filing
  • Period Q1 2024
  • Filing Date May 15, 2024
  • Form Type 13F-HR
  • Activity in Q1 2024
  • New Purchases 1 stocks
  • Additional Purchases 2 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 5 stocks
Track This Portfolio

Track Aquilo Capital Management, LLC Portfolio

Follow Aquilo Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aquilo Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aquilo Capital Management, LLC with notifications on news.